No definition available.
Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)
C3_PENIS_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
217 |
4. Check minimum number of eventsNone |
217 |
5. Include endpointsNone |
217 |
6. Filter based on genotype QC (FinnGen only) |
217 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 217 | - | 217 |
| Unadjusted period prevalence (%) | 0.10 | - | 0.10 |
| Median age at first event (years) | 66.87 | - | 66.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 112
- Matched controls
- 1120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
94.6
77
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
57.3
50
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
52.2
46
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
51.0
45
*
KGB00
NOMESCO Finland
Biopsy of penis
+∞
38.8
35
*
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
38.8
35
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
37.6
34
*
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
35.3
32
*
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
+∞
34.1
31
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
87.0
33.5
36
6
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
30.6
28
*
JN4BD
NOMESCO Finland
Extensive body CT
27.6
25.5
35
18
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
23.8
22
*
KGD05
NOMESCO Finland
Partial excision of body of penis
+∞
22.7
21
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
21.5
20
*
130
Kela drug reimbursment
Malignant tumour
+∞
21.5
20
*
KGH10
NOMESCO Finland
Operation for phimosis
18.9
21.3
33
24
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
20.4
19
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
19.3
18
*
N48.1
ICD-10 Finland
Balanoposthitis
17.3
18.2
29
22
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
+∞
18.2
17
*
H02AB02
ATC
dexamethasone; systemic
99.2
16.0
17
*
KGD96
NOMESCO Finland
Other partial excision of penis
+∞
16.0
15
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
12.6
15.9
29
30
JN4AD
NOMESCO Finland
Body CT examination
22.4
15.4
22
12
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
+∞
14.9
14
*
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
61.5
14.2
16
*
116
Kela drug reimbursment
Prostate cancer
+∞
13.8
13
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
13.8
13
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
13.8
13
*
TKD00
NOMESCO Finland
Dilatation of urethra
145.5
12.7
13
*
WX402
NOMESCO Finland
General anaesthesia
6.4
12.6
36
77
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
5.7
12.2
39
96
WX408
NOMESCO Finland
General anesthesy, balanced
4.8
11.7
46
141
XKD00
NOMESCO Finland
Uroflowmetry
4.8
11.5
45
137
UKC02
NOMESCO Finland
Cystoscopy
4.8
11.4
44
132
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.7
11.3
23
29
WZC30
NOMESCO Finland
Teaching
7.9
11.2
26
41
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
10.6
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.6
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.2
9.7
43
145
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
9.5
9
*
KGD10
NOMESCO Finland
Destruction of lesion of penis
+∞
9.5
9
*
KGC10
NOMESCO Finland
Total amputation of penis
+∞
9.5
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.5
9
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
9.5
9
*
Z51.5
ICD-10 Finland
Palliative care
15.8
9.0
14
10
ZZA00
NOMESCO Finland
Split skin graft
15.8
9.0
14
10
KDH10
NOMESCO Finland
Meatoplasty of urethra
54.3
8.8
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.1
8.7
24
48
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
97.0
8.5
9
*
WX240
NOMESCO Finland
Penis blockade
97.0
8.5
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.7
8.5
25
54
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
TKC20
NOMESCO Finland
Catheterisation of bladder
6.4
8.0
21
39
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
16.6
7.9
12
8
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
10.0
7.8
15
17
R33
ICD-10 Finland
Retention of urine
5.1
7.8
25
60
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
85.4
7.5
8
*
N48.8
ICD-10 Finland
Other specified disorders of penis
85.4
7.5
8
*
JN4CD
NOMESCO Finland
Very extensive body CT
17.2
7.4
11
7
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.4
7
*
8051/3-C60.9
ICD-O-3
Verrucous carcinoma, NOS, of penis, NOS
+∞
7.4
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.4
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.4
7
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
+∞
7.4
7
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.4
7
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
7.4
7
*
WX320
NOMESCO Finland
Spinalanesthesy
3.5
7.1
37
137
A03FA01
ATC
metoclopramide; systemic, rectal
5.7
7.1
20
41
J01DB01
ATC
cefalexin; oral
3.5
6.5
95
689
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
19.3
6.4
9
5
Y04
ICPC
Penis symptom/complaint other
28.4
6.3
8
*
8070/3-C60.0
ICD-O-3
Squamous cell carcinoma, NOS, of prepuce
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
13.5
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
135
619
4.13
23.26
6.7
3.5
—
—
—
0
0
157
894
3.73
17.64
6.5
3.6
18.3
619.3
e6/l
—
7
15
81
326
3.37
15.75
3.2
2.0
—
—
—
0
0
61
263
2.84
9.96
1.9
1.8
—
—
—
0
0
98
537
2.50
9.83
5.3
2.8
—
—
—
0
0
161
1117
2.71
9.60
13.0
5.4
83.3
75.3
u/l
1.67
151
1029
25
63
4.35
9.34
2.2
1.9
2.9
2.2
ug/l
0.12
18
56
115
693
2.40
9.18
10.8
6.0
1.2
1.2
mmol/l
1.04
96
590
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
54
4.42
8.48
2.5
2.4
0.3
0.3
u/ml
0.91
13
27
107
645
2.30
8.30
8.3
3.7
34.0
35.1
g/l
1.33
99
587
77
409
2.37
7.96
4.3
2.6
0.4
0.4
e6/l
0.03
61
302
104
639
2.21
7.49
10.1
5.5
1.2
1.2
mmol/l
1.02
96
564
52
239
2.55
7.30
4.1
2.7
0.8
0.7
e6/l
0.13
34
138
118
770
2.17
7.22
16.3
6.3
4.4
4.5
e9/l
0.13
107
678
38
159
2.69
6.40
4.3
3.4
—
—
—
0
0
50
254
2.26
5.52
4.0
2.6
1.4
1.0
e6/l
0.41
33
154
33
141
2.58
5.31
6.6
6.2
1.1
1.5
mmol/l
2.91
33
135
26
98
2.88
5.30
1.8
1.6
—
—
—
0
0
42
204
2.31
5.13
4.3
2.5
18.5
24.6
%
2.40
37
176
39
187
2.32
4.90
1.7
1.7
—
—
—
0
0
20
68
3.14
4.86
2.0
1.6
—
—
—
0
0
23
87
2.84
4.66
8.1
8.6
24.0
24.7
mmol/l
0.56
23
75
96
674
1.76
3.99
6.2
4.3
0.0
0.0
estimate
0.00
18
118
17
60
2.99
3.89
1.9
1.4
—
—
—
0
0
11
29
3.94
3.85
1.7
1.5
—
—
—
0
0
11
29
3.94
3.85
1.3
1.3
—
—
—
0
0
36
187
2.11
3.71
1.8
1.8
—
—
—
0
0
96
693
1.69
3.49
4.3
3.2
0.0
0.0
estimate
0.00
17
109
12
37
3.37
3.39
1.6
1.4
—
—
—
0
0
94
679
1.68
3.39
4.4
3.2
0.0
0.0
estimate
0.00
18
113
67
444
1.74
3.30
8.0
2.1
2.4
2.3
mmol/l
0.62
58
358
6
7
8.77
3.28
1.2
1.0
—
—
—
0
0
6
7
8.77
3.28
1.2
1.0
—
—
—
0
0
10
28
3.70
3.23
1.8
1.5
—
—
—
0
0
10
28
3.70
3.23
1.5
1.2
—
—
—
0
0
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
8
15
5.49
3.22
1.6
1.0
—
—
—
0
0
21
92
2.42
3.22
1.7
1.5
—
—
—
0
0
9
20
4.65
3.15
1.9
1.5
—
—
—
0
0
176
1520
1.84
3.09
29.9
13.5
33.9
27.1
mg/l
1.52
163
1180
6
8
7.67
3.07
1.0
1.3
—
—
—
0
0
67
454
1.69
3.01
3.4
2.8
29.8
37.6
u/l
1.50
62
428
77
545
1.64
2.92
4.6
3.4
—
—
—
0
0
7
13
5.52
2.89
1.9
1.6
—
—
—
0
0
7
13
5.52
2.89
2.4
1.6
163.8
2.8
u/ml
—
7
13
9
23
4.04
2.80
1.0
1.3
—
—
—
0
0
52
335
1.73
2.79
2.5
1.8
1266.6
1215.5
nmol/l
0.10
41
262
8
19
4.33
2.70
1.3
1.3
—
—
—
0
0
9
24
3.86
2.70
1.0
1.3
—
—
—
0
0
12
43
2.90
2.69
1.2
1.2
—
—
—
0
0
9
25
3.71
2.60
1.3
1.2
—
—
—
0
0
12
44
2.83
2.59
3.3
1.3
—
1.3
—
0
6
5
7
7.28
2.56
1.2
1.0
—
—
—
0
0
5
7
7.28
2.56
1.2
1.0
—
—
—
0
0
10
34
3.03
2.44
1.2
1.6
—
—
—
0
0
7
17
4.22
2.38
1.9
1.2
—
—
—
0
0
34
205
1.78
2.28
7.8
6.5
-0.1
1.1
mmol/l
0.82
29
149
57
397
1.59
2.24
2.4
2.1
3.4
2.9
mg/l
0.65
50
328
164
1434
1.59
2.24
27.1
12.2
76.3
76.3
ml/min/173m2
0.00
144
1178
10
37
2.78
2.13
1.7
1.6
—
0.2
—
0
13
5
10
5.09
2.08
1.6
1.4
—
—
—
0
0
6
15
4.08
2.05
1.8
1.3
10.5
15.8
ug/l
—
6
15
180
1628
1.62
1.92
31.7
16.8
4.0
4.0
mmol/l
0.08
175
1573
138
1191
1.44
1.77
32.8
15.9
14.2
13.7
%
2.91
138
1156
128
1091
1.42
1.76
4.6
3.8
17.9
11.7
mm/h
2.83
116
992
5
13
3.91
1.72
1.8
1.2
—
—
—
0
0
40
273
1.57
1.70
7.1
2.0
2.5
2.4
mmol/l
2.39
34
231
8
32
2.56
1.61
1.0
1.2
—
—
—
0
0
8
32
2.56
1.61
1.0
1.2
—
—
—
0
0
6
20
3.05
1.59
1.0
1.5
—
—
—
0
0
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
45
324
1.49
1.51
4.0
3.6
1.0
1.0
kg/l
0.13
15
50
21
125
1.75
1.50
4.3
1.9
68.1
67.2
g/l
0.20
21
109
21
125
1.75
1.50
8.3
3.8
0.7
1.8
mmol/l
0.78
15
94
5
16
3.17
1.44
2.2
1.9
—
—
—
0
0
6
23
2.65
1.37
1.5
1.1
—
—
—
0
0
178
1643
1.46
1.34
34.1
15.9
97.6
90.4
umol/l
0.80
178
1643
140
1244
1.35
1.31
7.2
3.9
30.5
2.1
ug/l
0.65
127
1103
11
55
2.05
1.29
2.9
2.3
38.9
36.2
u/l
0.16
11
49
13
70
1.91
1.27
2.1
4.3
—
—
—
0
0
81
667
1.34
1.26
2.2
2.0
90.9
91.2
pmol/l
0.02
48
393
52
401
1.39
1.21
1.7
1.5
17.0
18.8
nmol/l
0.55
47
343
7
32
2.23
1.09
3.7
3.8
62.3
24.4
mg/l
—
7
26
13
75
1.78
1.05
1.2
1.3
1216.5
235.3
u/ml
0.50
13
68
7
34
2.09
1.04
6.9
1.2
20.7
13.7
u/l
—
7
29
71
589
1.31
1.02
3.4
3.2
5727.8
1719.0
ng/l
1.05
62
505
7
35
2.03
1.01
2.0
1.3
—
—
—
0
0
11
61
1.85
1.00
1.1
1.6
—
—
—
0
0
16
102
1.61
0.93
1.8
2.1
28.2
36.6
u/l
0.55
11
86
16
102
1.61
0.93
1.4
1.5
—
—
—
0
0
174
1632
1.33
0.91
15.9
8.8
26.9
29.3
u/l
0.82
164
1552
66
551
1.28
0.90
4.2
2.6
228.5
191.0
ug/l
0.36
60
496
6
29
2.10
0.90
2.5
1.8
—
—
—
0
0
87
758
1.25
0.83
2.0
2.3
—
—
—
0
0
109
978
1.23
0.78
3.8
3.2
70.0
54.8
u/l
0.90
102
907
146
1352
1.24
0.77
24.7
14.3
38.0
40.4
%
1.40
91
878
38
304
1.30
0.71
1.4
1.7
1.2
1.3
mg/l
0.12
32
234
29
223
1.35
0.71
5.1
4.9
29.4
30.3
%
0.18
21
148
7
41
1.73
0.70
1.0
1.9
—
—
—
0
0
11
69
1.63
0.70
1.1
1.7
—
—
—
0
0
7
42
1.69
0.69
1.9
1.2
—
—
—
0
0
7
42
1.69
0.69
1.9
1.3
—
—
—
0
0
13
188
0.67
0.66
1.1
1.2
0.9
9.7
u/ml
—
5
72
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
149
1574
0.83
0.59
4.7
5.3
2.6
2.6
mmol/l
0.05
132
1428
54
464
1.22
0.57
3.7
2.6
14261.6
8921.3
umol/l
0.19
47
405
41
345
1.23
0.53
3.6
3.7
327.6
506.1
ng/l
0.30
32
285
80
719
1.18
0.52
4.8
3.9
41.6
54.9
ng/l
0.64
67
549
17
222
0.75
0.50
6.8
7.7
—
—
—
0
0
7
49
1.44
0.46
3.3
2.4
24.3
24.2
mmol/l
—
7
42
45
391
1.19
0.43
4.9
3.3
0.0
0.0
estimate
0.50
15
109
32
271
1.21
0.40
22.0
30.1
1.2
1.4
inr
—
6
32
0
18
0.00
0.40
0.0
3.4
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
8.0
—
0
11
6
44
1.37
0.34
1.5
1.5
—
—
—
0
0
93
992
0.89
0.33
3.1
2.9
14.2
15.1
pmol/l
3.10
82
873
55
499
1.14
0.31
2.7
2.1
71.2
75.1
nmol/l
0.59
46
435
144
1487
0.91
0.25
4.5
4.2
1.5
1.3
mmol/l
2.24
125
1336
149
1534
0.91
0.23
4.9
4.8
4.4
4.3
mmol/l
0.39
130
1392
5
38
1.32
0.23
4.6
1.3
0.0
0.0
g/l
—
5
33
10
124
0.80
0.22
1.4
1.2
—
—
—
0
0
127
1314
0.92
0.21
3.7
3.7
2.0
2.0
mu/l
0.04
107
1162
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
29.7
—
0
9
149
1524
0.93
0.16
4.4
4.7
1.2
1.3
mmol/l
1.66
128
1375
155
1516
1.08
0.16
4.7
4.9
6.2
6.2
mmol/l
0.19
139
1350
11
93
1.19
0.15
3.8
2.3
1.1
1.2
%
0.08
11
93
20
180
1.12
0.13
5.3
3.4
6.2
5.8
kpa
1.18
20
172
13
113
1.16
0.13
2.0
2.0
—
—
—
0
0
56
588
0.94
0.13
5.4
4.1
20.6
10.3
mg/mmol
0.69
43
399
5
44
1.14
0.10
4.6
1.3
0.0
0.0
g/l
—
5
39
5
48
1.04
0.09
4.6
1.2
36.9
37.5
g/l
—
5
36
101
987
1.04
0.09
5.9
3.7
20.2
24.3
%
1.66
53
465
145
1466
0.97
0.05
6.6
6.7
41.6
41.3
mmol/mol
0.15
125
1339
70
687
1.03
0.04
3.4
2.6
1.1
0.8
ug/l
0.49
46
454
15
151
0.99
0.00
5.3
2.7
5.7
4.6
kpa
0.53
15
142
38
375
1.02
0.00
2.0
1.7
1.7
1.4
mmol/l
0.98
30
306
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
0.00
4.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
12.9
—
0
6
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PENIS_EXALLC – Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).